Stonebridge Capital Management Inc Biogen Inc. Transaction History

Stonebridge Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 12, 2019	SELL	$219.29 - $241.72 $588,135 - $648,293	-2,682 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$216.71 - $338.96 $4,550 - $7,118	21 Added 0.79%	2,682 $634,000
Q4 2018 Jan 25, 2019	SELL	$278.5 - $352.75 $18,102 - $22,928	-65 Reduced 2.38%	2,661 $800,000
Q3 2018 Oct 17, 2018	SELL	$293.51 - $383.83 $10,272 - $13,434	-35 Reduced 1.27%	2,726 $964,000
Q2 2018 Jul 06, 2018	BUY	$257.52 - $306.91 $25,752 - $30,691	100 Added 3.76%	2,761 $825,000

Q1 2018 Apr 16, 2018	SELL	$260.13 - $367.91 $19,509 - $27,593	-75 Reduced 2.74%	2,661 $707,000
Q4 2017 Jan 29, 2018	BUY	$307.64 - $344.58 $841,703 - $942,770	2,736	2,736 $919,000

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Management Inc with notifications on news.